1. 142: CONVERT – An international randomised trial of concurrent chemo-radiotherapy (cCTRT) comparing twice-daily (BD) and once-daily (OD) radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status (PS). (January 2017) Authors: Faivre-Finn, C.; Snee, M.; Ashcroft, L.; Appel, W.; Barlesi, F.; Bhatnagar, A.; Bezjak, A.; Cardenal, F.; Fournel, P.; Harden, S.; Le Pechoux, C.; McMenemin, R.; Mohammed, N.; O'Brien, M.; Pantarotto, J.; Surmont, V.; Van Meerbeeck, J.; Woll, P.; Lorigan, P.; Blackhall, F. Journal: Lung cancer Issue: Volume 103(2017)Supplement 1 Page Start: S64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗